For transgender women (MTF) wishing to compete in women's events under the current USA Fencing policy, what type of medical treatment is required and for how long must it be completed? Additionally, what is the effective date of the revised Transgender & Non-Binary Athlete Eligibility Policy?
Navigate to the 'Transgender and Non-Binary Policy' page on usafencing.org. Locate the 'Current Transgender & Non-Binary Athlete Eligibility Policy' section. Identify the medical treatment requirement for transgender female (MTF) athletes to compete in women's events. Identify the duration for which this treatment must be completed. Locate the effective date of the 'Revised Transgender & Non-Binary Athlete Eligibility Policy'.
State that transgender women (MTF) must be treated with testosterone suppression medication. State that this treatment must be completed for one calendar year (12 months). State that the effective date of the revised policy is April 15, 2025.